tm logo
CLEOPATRARX
Live/Registered
REGISTERED

on 05 Mar 2024

Last Applicant/ Owned by

8000 Research Forest Dr., Ste. 115-101

The Woodlands

TX

77382

Serial Number

97642818 filed on 21st Oct 2022

Registration Number

7319589 registered on 05th Mar 2024

in the Principal Register

Correspondent Address

Monique A. Morneault

SCHERRER PATENT & TRADEMARK LAW, P.C.

17 E. CRYSTAL LAKE AVE.

CRYSTAL LAKE,IL 60014

Filing Basis

1. filed as use application

2. use application currently

Disclaimer

NO DATA

CLEOPATRARX

telemedicine services and physician services featuring counseling and treatment of perimenopause, menopause and post-menopause symptoms, including symptoms relating to cognitive decline and brain health; providing medical information featuring customized drug options for treating and managing symptoms relating to cognitive decline and brain health CLEOPATRA RX

Classification Information


Class [044]
Medical, Beauty & Agricultural Services


telemedicine services and physician services featuring counseling and treatment of perimenopause, menopause and post-menopause symptoms, including symptoms relating to cognitive decline and brain health; providing medical information featuring customized drug options for treating and managing symptoms relating to cognitive decline and brain health


First Use Date in General

31st Jul 2020

First Use Date in Commerce

30th Apr 2021

Mark Details


Serial Number

No 97642818

Mark Type

No Service Mark

Attorney Docket Number

No 1-CLE-002-T

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
05th Mar 2024REGISTERED-PRINCIPAL REGISTER
05th Mar 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
19th Dec 2023PUBLISHED FOR OPPOSITION
19th Dec 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
29th Nov 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10th Nov 2023APPROVED FOR PUB - PRINCIPAL REGISTER
26th Oct 2023TEAS/EMAIL CORRESPONDENCE ENTERED
25th Oct 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
25th Oct 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
04th Aug 2023ASSIGNED TO EXAMINER